- Home
- POAI
as of 12-04-2025 1:15pm EST
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
| Founded: | 2002 | Country: | United States |
| Employees: | N/A | City: | PITTSBURGH |
| Market Cap: | 6.5M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 27.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -149.54 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.76 - $45.90 | Next Earning Date: | 11-14-2025 |
| Revenue: | $1,664,407 | Revenue Growth: | 320.71% |
| Revenue Growth (this year): | 486.27% | Revenue Growth (next year): | 65.50% |
AI-Powered POAI Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare POAI vs Leading Stocks
See how POAI stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "POAI Predictive Oncology Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.